Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;10(13):741.
doi: 10.21037/atm-22-630.

Surface-based morphological patterns associated with neuropsychological performance, symptom severity, and treatment response in Parkinson's disease

Affiliations

Surface-based morphological patterns associated with neuropsychological performance, symptom severity, and treatment response in Parkinson's disease

Jiajie Mo et al. Ann Transl Med. 2022 Jul.

Abstract

Background: Surface-based cortical morphological patterns provide insight into the neural mechanisms of Parkinson's disease (PD). Explorations of the relationship between these patterns and the clinical assessment and treatment effects could be used to inform early intervention and treatment planning.

Methods: We recruited 78 PD patients who underwent presurgical evaluation and 55 healthy controls. We assessed neocortical sulcal depth, gyrification index, and fractal dimension and applied a general linear model using the multivariate Hotelling's t-test to determine the joint effect of surface-based shape abnormalities in PD. The relationship between the neuroimaging pattern and clinical assessment was investigated using a multivariate linear regression model. A machine learning model based on surfaced-based features was used to predict responses to medication and deep brain stimulation (DBS).

Results: The surface-based neuroimaging pattern of PD included decreases in morphological metrics in the gyrus (left: F=4.32; right: F=4.13), insular lobe (left: F=4.87; right: F=4.53), paracentral lobe (left: F=4.01; right: F=4.26), left posterior cingulate cortex (F=4.48), and left occipital lobe (F=4.27, P<0.01). This pattern was significantly associated with cognitive performance and motor symptoms (P<0.01). The machine learning model using morphological metrics was able to predict the drug response in the tremor score (R=-0.34, P<0.01) and postural instability and gait disorders score (R=0.24, P=0.04).

Conclusions: We identified the surface-based neuroimaging pattern associated with PD and explored its association with clinical assessment. Our findings suggest that these morphological indicators have potential value in informing personalized medicine and patient management.

Keywords: Parkinson’s disease (PD); neuroimaging patterns; neurophysiological performance; symptom severity; treatment response.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-630/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Surface-based neuroimaging pattern of Parkinson’s disease (PD). (A) Univariate analysis showed regions of widespread decreased sulcal depth, gyrification index, and fractal dimension in PD patients compared to healthy controls. Only significant clusters (P<0.01) are shown, and the vertex-wise Student’s t value is indicated by the color bar. (B) Multivariate analysis assessed the joint distribution of changes to sulcal depth, gyrification index, and fractal dimension, finding significant group differences in the bilateral precentral gyrus, insular lobe, paracentral lobe, left posterior cingulate cortex, and left occipital lobe. Only significant clusters (P<0.01) are shown, and the Hotelling’s F value is indicated by the color bar. The statistical model was corrected for cortical thickness and demographic information.
Figure 2
Figure 2
The association between the neuroimaging pattern and clinical assessment measures. Regression maps identified associations between the neuroimaging pattern and clinical assessment measures. (A) Differences in the right frontal lobe were significantly associated with MMSE score. (B) Differences in the right insular lobe were significantly associated with the UPDRS-III total score, left insular lobe with the Tremor score, and bilateral insular and left PCC with the PIGD score. Only significant clusters (P<0.01) are shown, Hotelling’s F value is indicated using the color bar. Arrows indicate the significant clusters that are too small to easily see. The statistical model corrected for cortical thickness and demographic information. MMSE, mini-mental state examination; UPDRS, unified Parkinson’s disease rating scale; PCC, posterior cingulate cortex; PIGD, postural instability and gait disorders.
Figure 3
Figure 3
Prediction of drug response. The neuroimaging pattern successfully predicted the response to medication in the form of the Tremor score and the PIGD score. The X-axis represents the actual value, while the Y-axis shows the predictive value, and the line represents the slope. *: statistical significance. PIGD, postural instability and gait disorders.

Similar articles

Cited by

References

    1. Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet 2021;397:2284-303. 10.1016/S0140-6736(21)00218-X - DOI - PubMed
    1. Groiss SJ, Wojtecki L, Südmeyer M, et al. Deep brain stimulation in Parkinson’s disease. Ther Adv Neurol Disord 2009;2:20-8. 10.1177/1756285609339382 - DOI - PMC - PubMed
    1. Narme P, Mouras H, Roussel M, et al. Emotional and cognitive social processes are impaired in Parkinson’s disease and are related to behavioral disorders. Neuropsychology 2013;27:182-92. 10.1037/a0031522 - DOI - PubMed
    1. Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 2021;7:47. 10.1038/s41572-021-00280-3 - DOI - PubMed
    1. Getz SJ, Levin B. Cognitive and Neuropsychiatric Features of Early Parkinson’s Disease. Arch Clin Neuropsychol 2017;32:769-85. 10.1093/arclin/acx091 - DOI - PubMed